Skip Navigation
 
Home | About CDC | Media Relations | A-Z Index | Contact Us
   
Centers for Disease Control & Prevention
CDC en Español 
Sexually Transmitted Diseases

ChlamydiaScreening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections - 2002


Previous Page Table of Contents Next Page 

Section on this page:

  • References

References

  1. Groseclose SL, Zaidi AA, DeLisle SJ, Levine WC, St. Louis ME. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999;26:339--44.
  2. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling PF, Mardh P-A, et al., eds. Sexually transmitted diseases. 3rd ed. New York, NY: McGraw-Hill, 1999:407--22.
  3. Rees E. Treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980;138:1042--7.
  4. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984;310:545--9.
  5. Westrom L, Joesoef R, Reynolds G, Hadgu A, Thompson SE. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopy results. Sex Transm Dis 1992;19:185--92.
  6. Institute of Medicine, Division of Health Promotion and Disease Prevention. Hidden epidemic: confronting sexually transmitted diseases. Eng TR, Butler WT, eds. Washington, DC: National Academy Press, 1997.
  7. CDC. Sexually transmitted disease surveillance, 2000. Atlanta, GA: US Department of Health and Human Services, CDC, 2001.
  8. CDC. Chlamydia trachomatis genital infections---United States, 1995. MMWR 1997;46:193--8.
  9. CDC. Sexually transmitted disease surveillance 2000 supplement: Chlamydia Prevalence Monitoring Project. Atlanta, GA: US Department of Health and Human Services, CDC, 2002.
  10. Hook EW III, Handsfield HH. Gonococcal infections in the adult [Chapter 32]. In: Holmes KK, Sparling PF, Mardh P-A, et al., eds. Sexually Transmitted Diseases. 3rd ed. New York, NY: McGraw-Hill, 1999:451--66.
  11. CDC. Gonorrhea---United States, 1998. MMWR 2000;49:538--42.
  12. Knapp JS, Koumans EH. Neisseria and Branhamella. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 7th ed. Washington, DC: American Society of Microbiology, 1999:586--603.
  13. Koumans EH, Johnson RE, Knapp JS, St. Louis ME. Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis 1998;27:1171--80.
  14. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997;10:160--84.
  15. Chernesky M, Morse S, Schachter J. Newly available and future laboratory tests for sexually transmitted diseases (STDs) other than HIV. Sex Transm Dis 1999;26(4Suppl.):S8--11.
  16. Chernesky MA. Nucleic acid tests for the diagnosis of sexually transmitted diseases. FEMS Immunol Med Microbiol 1999;24:437--46.
  17. Davies PO, Ridgway GL. Role of polymerase chain reaction and ligase chain reaction for the detection of Chlamydia trachomatis. Int J STD AIDS 1997;8:731--8.
  18. Domeika M. Diagnosis of infections due to Chlamydia trachomatis. Acta Obstet Gynecol Scand 1997;164(Suppl):121--7.
  19. Schachter J. DFA, EIA, PCR, LCR and other technologies: what tests should be used for diagnosis of chlamydia infections? Immunol Invest 1997;26:157--61.
  20. Taylor-Robinson D. Evaluation and comparison of tests to diagnose Chlamydia trachomatis genital infections. Hum Reprod 1997;12(11 Suppl):113--20.
  21. Guaschino S, De Seta F. Update on Chlamydia trachomatis [Review]. Annals N Y Acad Sci 2000;900:293--300.
  22. Hall GS. Laboratory diagnosis of C. trachomatis and N. gonorrhoeae using molecular methods: what's new! ASCP Spring 2001 Teleconference Series. Chicago, IL: American Society of Clinical Pathologists, 2001.
  23. Mardh PA. Chlamydia screening---yes, but of whom, when, by whom, and with what? Annals N Y Acad Sci 2000;900:286--92.
  24. Code of Federal Regulations. Title 42, Chapter IV, part 493---Laboratory requirements.
  25. Pate MS, Hook EW. Laboratory to laboratory variation in Chlamydia trachomatis culture practices. Sex Transm Dis 1995;22:322--6.
  26. Yoder BL, Stamm WE, Koester CM, Alexander ER. Microtest procedure for isolation of Chlamydia trachomatis. J Clin Microbiol 1981;13:1036--9.
  27. Stamm WE, Tam M, Koester M, Cles L. Detection of Chlamydia trachomatis inclusions in McCoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol 1983;17:666--8.
  28. Barnes RC. Laboratory diagnosis of human chlamydial infections. Clin Microbiol Rev 1989;2:119--36.
  29. Hammerschlag MR, Ajl S, Laraque D. Inappropriate use of nonculture tests for the detection of Chlamydia trachomatis in suspected victims of child sexual abuse: a continuing problem. Pediatrics 1999;104:1137--9.
  30. CDC. False-positive results with the use of chlamydial tests in the evaluation of suspected sexual abuse---Ohio 1990 [Epidemiologic notes and reports]. MMWR 1991;39:932--5.
  31. CDC. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR 1993;42(No. RR-12):1--39.
  32. Jephcott AE. Microbiological diagnosis of gonorrhoea. Genitourinary Medicine 1997;73:245--52.
  33. Mirrett S, Reller LB, Knapp JS. Neisseria gonorrhoeae strains inhibited by vancomycin in selective media and correlation with auxotype. J Clin Microbiol 1981;14:94--9.
  34. Bonin P, Tanino TT, Handsfield HH. Isolation of Neisseria gonorrhoeae on selective and nonselective media in a sexually transmitted disease clinic. J Clin Microbiol 1984;19:218--20.
  35. Tang Y-W, Persing DH. Molecular detection and identification of microorganisms. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 7th ed. Washington, DC: ASM Press, 1999:215--44.
  36. Pfaller MA. Molecular approaches to diagnosing and managing infectious diseases: practicality and costs. Emerg Infect Dis 2001;7:312--8.
  37. Østergaard L, Moller JK, Andersen B, Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. BMJ 1996;313:1186--9.
  38. Wiesenfeld HC, Heine RP, Rideout A, Macio I, DiBiasi F, Sweet RL. Vaginal introitus: a novel site for Chlamydia trachomatis testing in women. Am J Obstet Gynecol 1996;174:1542--6.
  39. Witkin SS, Inglis SR, Polaneczky M. Detection of Chlamydia trachomatis and Trichomonas vaginalis by polymerase chain reaction in introital specimens from pregnant women. Am J Obstet Gynecol 1996;175:165--7.
  40. Hook EW III, Smith K, Mullen C, et al. Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997;35:2133--5.
  41. Stary A, Najim B, Lee HH. Vulval swabs as alternative specimens for ligase chain reaction detection of genital chlamydial infection in women. J Clin Microbiol 1997;35:836--8.
  42. Tabrizi SN, Paterson B, Fairley CK, Bowden FJ, Garland SM. Self-administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis 1997;176:289--92.
  43. Jeremias J, Tolbert V, Witkin SS. Detection of Chlamydia trachomatis and Trichomonas vaginalis in the vaginal introitus, posterior vagina, and endocervix by polymerase chain reaction. Methods Mol Biol 1998;92:227--37.
  44. Polaneczky M, Quigley C, Pollock L, Dulko D, Witkin SS. Use of self-collected vaginal specimens for detection of Chlamydia trachomatis infection. Obstet Gynecol 1998;91:375--8.
  45. Stary A, Schuh E, Kerschbaumer M, Gotz B, Lee H. Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods. J Clin Microbiol 1998;36:2666--70.
  46. Thomas BJ, Pierpoint T, Taylor-Robinson D, Renton AM. Sensitivity of the ligase chain reaction assay for detecting Chlamydia trachomatis in vaginal swabs from women who are infected at other sites. Sex Transm Infect 1998;74:140--1.
  47. Carder C, Robinson AJ, Broughton C, Stephenson JM, Ridgway GL. Evaluation of self-taken samples for the presence of genital Chlamydia trachomatis infection in women using the ligase chain reaction assay. Int J STD AIDS 1999;10:776--9.
  48. Domeika M, Bassiri M, Butrimiene I, Venalis A, Ranceva J, Vasjanova V. Evaluation of vaginal introital sampling as an alternative approach for the detection of genital Chlamydia trachomatis infection in women. Acta Obstet Gynecol Scand 1999;78:131--6.
  49. Moller JK, Andersen B, Olesen F, Lignell T, Østergaard L. Impact of menstrual cycle on the diagnostic performance of LCR, TMA, and PCE for detection of Chlamydia trachomatis in home obtained and mailed vaginal flush and urine samples. Sex Transm Infect 1999;75:228--30.
  50. Hook EW III, Ching SF, Stephens J, Hardy KF, Smith KR, Lee HH. Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997;35:2129--32.
  51. Hammerschlag MR, Roblin PM, Gelling M, Tsumura N, Jule JE, Kutlin A. Use of polymerase chain reaction for the detection of Chlamydia trachomatis in ocular and nasopharyngeal specimens from infants with conjunctivitis. Pediatr Infect Dis J 1997;16:293--7.
  52. Kowalski RP, Uhrin M, Karenchak LM, Sweet RL, Gordon YJ. Evaluation of the polymerase chain reaction test for detecting chlamydial DNA in adult chlamydial conjunctivitis. Ophthalmology 1995;102:1016--9.
  53. Kessler HH, Pierer K, Stuenzner D, Auer-Grumbach P, Haller EM, Marth E. Rapid detection of Chlamydia trachomatis in conjunctival, pharyngeal, and urethral specimens with a new polymerase chain reaction assay. Sex Transm Dis 1994;21:191--5.
  54. Martin DH, Cammarata C, Van der Pol B, et al. Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol 2000;38:3544--9.
  55. Crotchfelt KA, Welsh LE, DeBonville D, Rosenstraus M, Quinn TC. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol 1997;35:1536--40.
  56. Van der Pol B, Martin DH, Schachter J, et al. Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol 2001;39:3092--8.
  57. Becton Dickinson. BDProbeTec™ ET Chlamydia trachomatis and Neisseria gonorrhoeae amplified DNA assays [Package insert]. Sparks, MD: Becton Dickinson, 1999.
  58. Kluytmans JAJW, Niesters HGM, Mouton JW, et al. Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1991;29:2685--9.
  59. Modarress KJ, Cullen AP, Jaffurs WJ Sr, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in swab specimens by the Hybrid Capture II and PACE 2 nucleic acid probe tests. Sex Transm Dis 1999;26:303--8.
  60. Zubrzycki L. Non-culture tests for the diagnosis of gonorrhea [Review]. Adv Exp Med Biol 1990;263:77--88.
  61. Janik A, Juni E, Heym GA. Genetic transformation as a tool for detection of Neisseria gonorrhoeae. J Clin Microbiol 1976;4:71--81.
  62. Jaffe HW, Kraus SJ, Edwards TA, Weinberger SS, Zubrzycki L. Diagnosis of gonorrhea using a genetic transformation test on mailed clinical specimens. J Infect Dis 1982;146:275--9.
  63. Butler LO, Knight RDJ. Laboratory diagnosis of gonococcal infection by genetic transformation. J Clin Microbiol 1982;15:810--4.
  64. Zubrzycki L, Weinberger SS. Laboratory diagnosis of gonorrhoea by a simple transformation test with a temperature-sensitive mutant of Neisseria gonorrhoeae. Sex Transm Dis 1980;7:183--7.
  65. Kellogg JA, Seiple JW, Hick ME. Cross-reaction of clinical isolates of bacteria and yeasts with the Chlamydiazyme test for chlamydial antigen, before and after use of a blocking reagent. Am J Clin Pathol 1992;97:309--12.
  66. Stamm WE. Diagnosis of Chlamydia trachomatis genitourinary infections. Ann Intern Med 1988;108:710--7.
  67. Suchland KL, Counts JM, Stamm WE. Laboratory methods for detection of Chlamydia trachomatis: survey of laboratories in Washington State. J Clin Microbiol 1997;35:3210--4.
  68. Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996;72:422--6.
  69. Ison CA. Laboratory methods in genitourinary medicine: methods of diagnosing gonorrhoea. Genitourin Med 1990;66:453--9.
  70. Hadgu A. Bias in the evaluation of DNA-amplification tests for detecting Chlamydia trachomatis. Statist Med 1997;16:1391--9.
  71. Miller WC. Bias in discrepant analysis: when two wrongs don't make a right. J Clin Epidemiol 1998;51:219--31.
  72. Lipman HB, Astles JR. Quantifying the bias associated with use of discrepant analysis. Clin Chem 1998;44:108--15.
  73. McAdam AJ. Discrepant analysis: how can we test a test? J Clin Microbiol 2000;38:2027--9.
  74. Green TA, Black CM, Johnson RE. Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysis. J Clin Microbiol 1998;36:375--81.
  75. Hadgu A. Discrepant analysis: a biased and an unscientific method for estimating test sensitivity and specificity. J Clin Epidemiol 1999;52:1231--7.
  76. Schachter J, Moncada J, Whidden R, et al. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis 1995;172:1411--4.
  77. Van der Pol B, Quinn TC, Gaydos CA, et al. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol 2000;38:1105--12.
  78. Black CM, Marrazzo J, Johnson RE, et al. Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis in women with use of an improved reference standard. J Clin Microbiol (in press).
  79. Newhall WJ, Johnson RE, DeLisle S, et al. Head-to-head evaluation of five chlamydia tests relative to a quality-assured culture standard. J Clin Microbiol 1999;37:681--5.
  80. Johnson RE, Green TA, Schachter J, et al. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol 2000;38:4382--6.
  81. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York, NY: John Wiley & Sons, 1981.
  82. Weiss NS. Clinical epidemiology: the study of the outcome of illness. Monographs in epidemiology and biostatistics, vol 27. 2nd ed. New York, NY: Oxford University Press, 1996.
  83. Noe DA. Diagnostic classification [Ch. 3]. In: Noe DA, Rock RC, Grochow LB, Kahn SB Perlin E, eds. Laboratory medicine: the selection and interpretation of clinical laboratory studies. Baltimore, MD: Williams & Wilkins, 1994:27--43.
  84. Becton Dickinson. BDProbeTec™ ET Chlamydia trachomatis and Neisseria gonorrhoeae amplified DNA assays [Package insert, table 15]. Sparks, MD: Becton Dickinson, 2001.
  85. Gen-Probe. Gen-Probe APTIMA® Combo 2 Assay [Package insert]. San Diego, CA: Gen-Probe, 2001.
  86. Stary A. Correct samples for diagnostic tests in sexually transmitted diseases: which sample for which test? [Review]. FEMS Immunol Med Microbiol 1999;24:455--9.
  87. Toye B, Peeling RW, Jessamine P, Claman P, Gemmill I. Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay. J Clin Microbiol 1996;34:1396--1400.
  88. Van der Pol B, Ferrero DV, Buck-Barrington L, et al. Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol 2001;39:1008--16.
  89. Shafer MA, Schachter J, Moncada J, et al. Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA 1993;270:2065--70.
  90. Neu N, Grumet S, McNees A, et al. Screening for Chlamydia trachomatis in young men by ligase chain reaction. Pediatr Infect Dis J 1999;18:649--50.
  91. Sellors JW, Mahony JB, Pickard L, et al. Screening urine with a leukocyte esterase strip and subsequent chlamydial testing of asymptomatic men attending primary care practitioners. Sex Transm Dis 1993;20:152--7.
  92. McKenna JG, Fallon RJ, Moyes A, Young H. Anogenital non-gonococcal Neisseriae: prevalence and clinical significance. Int J STD AIDS 1993;4:8--12.
  93. Knapp JS, Hook EW III. Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults. J Clin Microbiol 1988;26:896--900.
  94. Barlow D. Diagnosis of oropharyngeal gonorrhoea [Review]. Genitourin Med 1997;73:16--7.
  95. Young H, Anderson J, Moyes A, McMillan A. Non-cultural detection of rectal and pharyngeal gonorrhoea by the Gen-Probe® PACE® 2 assay. Genitourin Med 1997;73:59--62.
  96. Miller WC, Hoffman IF, Owen-O'Dowd J, et al. Selective screening for chlamydial infection: which criteria to use? Am J Prev Med 2000;18:115--22.
  97. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies. Ann Intern Med 1998;128:277--84.
  98. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national Chlamydia control strategy. Sex Transm Dis 1997;24:131--41.
  99. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986;255:1730--4.
  100. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993;20:28--35.
  101. Weinstock HS, Bolan GA, Kohn R, Balladares C, Back A, Oliva G. Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations? Am J Epidemiol 1992;135:41--7.
  102. Gunn RA, Hillis SD, Shirey P, Waterman SH, Greenspan JR. Chlamydia trachomatis infection among Hispanic women in the California-Mexico border area, 1993: establishing screening criteria in a primary care setting. Sex Transm Dis 1995;22:329--34.
  103. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993;138:143--53.
  104. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362--6.
  105. US Preventive Services Task Force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med 2001;20(3Suppl):90--4.
  106. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ, Hadgu A. Screening women for gonorrhea: demographic screening criteria for general clinical use. Am J Public Health 1997;87:1535--8.
  107. Dean D, Ferrero D, McCarthy M. Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection. J Clin Microbiol 1998;36:94--9.
  108. Beebe JL, Rau MP, Albrecht KD. Confirmatory testing of Chlamydia trachomatis Syva enzyme immunoassay gray zone specimens by Syva direct fluorescent antibody test. Sex Transm Dis 1993;20:140--2.
  109. Chan EL, Brandt K, Horsman GB. 1-year evaluation of Syva MicroTrak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in a high-volume laboratory. J Clin Microbiol 1994;32:2208--11.
  110. Fonseca K, Megran DW, Anand CM. Detection of Chlamydia trachomatis antigen by enzyme immunoassay: importance of confirmatory testing. J Clin Pathol 1995;48:214--7.
  111. Østergaard L, Moller JK. Use of PCR and direct immunofluorescence microscopy for confirmation of results obtained by Syva MicroTrak chlamydia enzyme immunoassay. J Clin Microbiol 1995;33:2620--3.
  112. Tong CY, Donnelly C, Hood N. Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation by PCR and direct immunofluorescent antibody test. J Clin Pathol 1997;50:681--5.
  113. Chui L, Kakulphimp J, Detwiler B, Prasad E. Algorithm to detect Chlamydia trachomatis by polymerase chain reaction on specimens extracted for enzyme immunoassay. Diagn Microbiol Infect Dis 1998;32:185--90.
  114. Kacena KA, Quinn SB, Hartman SC, Quinn TC, Gaydos CA. Pooling of urine samples for screening for Neisseria gonorrhoeae by ligase chain reaction: accuracy and application. J Clin Microbiol 1998;36:3624--8.
  115. Kacena KA, Quinn SB, Howell MR, Madico GE, Quinn TC, Gaydos CA. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998;36:481--5.
  116. Krepel J, Patel J, Sproston A, et al. Impact on accuracy and cost of ligase chain reaction testing by pooling urine specimens for the diagnosis of Chlamydia trachomatis infections. Sex Transm Dis 1999;26:504--7.
  117. Morre SA, Meijer CJLM, Munk C, et al. Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: cost-saving strategy for epidemiological studies and screening programs. J Clin Microbiol 2000;38:1679--80.
  118. Peeling RW, Toye B, Jessamine P, Gemmill I. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect 1998;74:66--70.
  119. Kapala J, Copes D, Sproston A, et al. Pooling cervical swabs and testing by ligase chain reaction are accurate and cost-saving strategies for diagnosis of Chlamydia trachomatis. J Clin Microbiol 2000;38:2480--3.
  120. Lisby G, Scheibel J, Abrahamsson L-O, Christensen ES, Paloheimo S. Detection of Chlamydia trachomatis in individual and pooled endocervical and urethral scrapes by a commercially available polymerase chain reaction. APMIS 1994;102:797--800.
  121. Marrazzo JM, Whittington WL, Celum CL, et al. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis 2001;28:219--25.
  122. Bowden FJ. Reappraising the value of urine leukocyte esterase testing in the age of nucleic acid amplification. Sex Transm Dis 1998;25:322--6.
  123. Genc M, Ruusuvaara L, Mardh PA. Economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA 1993;270:2057--64.
  124. Shafer M-A, Schachter J, Moscicki AB, et al. Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA 1989;262:2562--6.
  125. Kellogg JA, Seiple JW, Klinedinst JL, Stroll E. Diff-Quik stain as a simplified alternative to Papanicolaou stain for determination of quality of endocervical specimens submitted for PCR detection of Chlamydia trachomatis. J Clin Microbiol 1996;34:2590--2.
  126. Kellogg JA, Seiple JW, Murray CL, Levisky JS. Effect of endocervical specimen quality on detection of Chlamydia trachomatis and on the incidence of false-positive results with the Chlamydiazyme method. J Clin Microbiol 1990;28:1108--13.
  127. Phillips RS, Hanff PA, Kauffman RS, Aronson MD. Use of a direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecologic care. J Infect Dis 1987;156:575--81.
  128. Kellogg JA, Seiple JW, Klinedinst JL, Levisky JS. Impact of endocervical specimen quality on apparent prevalence of Chlamydia trachomatis infections diagnosed using an enzyme-linked immunosorbent assay method. Arch Pathol Lab Med 1991;115:1223--7.
  129. Kellogg JA, Seiple JW, Klinedinst JL, Stroll ES, Cavanaugh SH. Improved PCR detection of Chlamydia trachomatis by using an altered method of specimen transport and high-quality endocervical specimens. J Clin Microbiol 1995;33:2765--7.
  130. Livengood CH 3rd, Schmitt JW, Addison WA, Wrenn JW, Magruder-Habib K. Direct fluorescent antibody testing for endocervical Chlamydia trachomatis: factors affecting accuracy. Obstet Gynecol 1988;72:803--9.
  131. Welsh LE, Quinn TC, Gaydos CA. Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections. J Clin Microbiol 1997;35:3078--81.
  132. Beebe JL, Gershman KA, Kelley JK, Hagner D, Creede P. How adequate is adequate for the collection of endocervical specimens for Chlamydia trachomatis testing? Sex Transm Dis 1999;26:579--83.
  133. Kallings I, Mardh PA. Sampling and specimen handling in the diagnosis of genital Chlamydia trachomatis infections. Scand J Infect Dis 1982;32:21--4.
  134. Mahony JB, Chernesky MA. Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens. J Clin Microbiol 1985;22:865--7.
  135. Mardh P-A, Zeeberg B. Toxic effect of sampling swabs and transportation test tubes on the formation of intracytoplasmic inclusions of Chlamydia trachomatis in McCoy cell cultures. British Journal of Venereal Disease 1981;57:268--72.
  136. Smith TF, Weed LA. Evaluation of calcium alginate-tipped aluminum swabs transported in Culturettes containing ampules of 2-sucrose phosphate medium for recovery of Chlamydia trachomatis. Am J Clin Pathol 1983;80:213--5.
  137. Moncada J, Schachter J, Shipp M, Bolan G, Wilber J. Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol 1989;27:1863--6.
  138. Jones RB, Katz BP, Van der Pol B, Caine VA, Batteiger BE, Newhall WJ. Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens. J Clin Microbiol 1986;24:1029--33.
  139. Judson FN, Werness BA. Combining cervical and anal-canal specimens for gonorrhea on a single culture plate. J Clin Microbiol 1980;12:216--9.
  140. Symington DA. Improved transport system for Neisseria gonorrhoeae clinical specimens. J Clin Microbiol 1975;2:498--503.
  141. Chapel TA, Smeltzer M, Dassel R. Effect of delaying incubation in a CO2-enriched environment on gonococci. Health and Laboratory Science 1976;13:45--48.
  142. Martin JE Jr, Lester A. Transgrow, a medium for transport and growth of Neisseria gonorrhoeae and Neisseria meningitidis. HSMHA Health Reports 1971;86:30--3.
  143. Evangelista AT, Beilstein HR. Cumitech 4A - Laboratory diagnosis of gonorrhea. Washington, DC: ASM Press, 1993.
  144. Baron EJ, Cassell GH, Duffy LB, et al. Cumitech 17A - Laboratory diagnosis of female genital tract infections. Washington, DC: ASM, 1993.
  145. Lossick J, DeLisle S, Fine D, Mosure D, Lee V, Smith C. Regional program for widespread screening for Chlamydia trachomatis in family planning clinics. In: Bowie WR, Caldwell HD, Jones RP, et al., eds. Chlamydial infections: proceedings of the 7th international symposium on human chlamydial infections. New York, NY: Cambridge University Press, 1990:575--9.
  146. CDC. Recall of LCx® Neisseria gonorrhoeae assay and implications for laboratory testing for N. gonorrhoeae and Chlamydia trachomatis [Notice to readers]. MMWR 2002;51:709.
  147. Castriciano S, Luinstra K, Jang D, et al. Accuracy of results obtained by performing a second ligase chain reaction assay and PCR analysis on urine samples with positive or near-cutoff results in the LCx test for Chlamydia trachomatis. J Clin Microbiol 2002;40:2632--4.
  148. Akduman D, Ehret JM, Messina K, Ragsdale S, Judson FN. Evaluation of a strand displacement amplification assay (BD ProbeTec-SDA) for detection of Neisseria gonorrhoeae in urine specimens. J Clin Microbiol 2002;40:281--3.
  149. Mulcahy GM, Albanese EA, Bachl BL. Reproducibility of the Roche Amplicor polymerase chain reaction assay for detection of infection by Chlamydia trachomatis in endocervical specimens. Clin Chem 1998;44:1575--8.
  150. Parks KS, Dixon PB, Richey CM, Hook EW III. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997;24:229--35.
  151. Peterson EM, Darrow V, Blanding J, Aarnaes S, De La Maza LM. Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test. J Clin Microbiol 1997;35:957--9.
  152. CDC.Sexually transmitted diseases treatment guidelines: 2002. MMWR 2002;51(No. RR-6):1--80.
  153. Bianchi A, Bogard M, Cessot G, Bohbot JM, Malkin JE, Alonso JM. Kinetics of Chlamydia trachomatis clearance in patients with azithromycin, as assessed by first void urine testing by PCR and transcription-mediated amplification [Note]. Sex Transm Dis 1998;25:366--7.
  154. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998;177:417--24.
  155. Morre SA, Sillekens PT, Jacobs MV, et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol Pathol 1998;51:149--54.
  156. Hanks JW, Scott CT, Butler CE, Wells DW. Evaluation of a DNA probe assay (Gen-Probe PACE 2) as the test of cure for Neisseria gonorrhoeae genital infections. J Pediatr 1994;125:161--2.
  157. White DJ, Mann CH, Matthews RS, Leeming JG, Clay JC. Value of tests of cure following cervical chlamydial infection. Int J STD AIDS 1993;4:5--7.
  158. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy: evidence against persistent infection. JAMA 1993;270:2071--5.
  159. Cerin A, Grillner L, Persson E. Chlamydia test monitoring during therapy. Int J STD AIDS 1991;2:176--9.
  160. Ferris DG, Lawler FH, Horner RD, Jernigan JC, Crout FV. Test of cure for genital Chlamydia trachomatis infection in women. J Fam Pract 1990;31:36--41.

 

Previous Page Table of Contents Next Page